Treatment with benralizumab (Fasenra) achieved remission at 36 and 48 weeks at rates similar to those of mepolizumab (Nucala) in a head-to-head phase 3 trial of the two drugs.
The rise in measles outbreaks and deaths is not surprising, given the recent decline in vaccination rates, said an official of the US Centers for Disease Control and Prevention.
The first year of the COVID-19 pandemic is associated with a 50% decline in working memory and executive function among older adults, a new UK study suggests.
The hero title can be an inspiring way to honor medical work. But there is a growing belief that while superhuman effort is indeed heroic, superhuman expectations are a systemic problem.